Congress legalizes intoxicating hemp drinks, imposes regressive tax

What it does

This bill creates a federal regulatory framework for hemp-derived beverages (non-alcoholic drinks containing cannabinoids like CBD or low-dose THC). It establishes a three-tier distribution system (manufacturers → wholesalers → retailers), requires FDA food-safety oversight, imposes an 8-cent-per-milligram federal excise tax on THC content, mandates strict labeling and advertising rules, and sets a 21-year-old minimum purchase age. The bill allows hemp-derived beverages to contain up to 5 milligrams of intoxicating THC per serving, overriding stricter federal limits in existing hemp law.

Why we flagged it

The bill's primary function is to establish federal regulation of a new beverage category and impose a novel excise tax on THC content. While framed as 'parity,' it actually creates a permissive regime that overrides stricter existing hemp limits and introduces a new revenue stream.

What the text implies

• The bill delegates to the Administrator (TTB) and FDA the power to define which cannabinoid combinations are 'harmful' (Section 4(3)(c)) without statutory criteria, creating regulatory uncertainty and potential for inconsistent enforcement.
• The 8-cent-per-milligram excise tax is regressive and may disproportionately burden lower-income consumers; a 5mg serving (the legal maximum) would cost 40 cents in federal tax alone, compounding state/local taxes.
• The bill permits intermediate hemp-derived products to temporarily exceed THC limits during manufacturing (Section 2(2)), creating a loophole for products in the supply chain that could be diverted or mishandled.
• FDA's authority to determine 'adulteration' based on cannabinoid interactions with added substances (caffeine, melatonin, etc.) is broad and undefined; the bill does not specify what evidence or testing standard applies.
• State preemption is limited (Section 4(7)) — states retain authority to ban hemp-derived beverages entirely or impose stricter rules, creating a patchwork market that may favor large manufacturers with multi-state compliance infrastructure.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Citizens gain consumer protections (FDA oversight, labeling requirements, age restrictions, recall authority) and clarity on a previously unregulated product category. However, the bill legalizes and normalizes a new intoxicating product with limited long-term safety data, imposes a regressive per-milligram tax that may increase consumer costs, and delegates critical safety determinations (e.g., what cannabinoid combinations are 'harmful') to agency discretion without statutory guardrails.

Who stands to gain

• beverage manufacturers (existing and new entrants in hemp-derived category)
• wholesalers and distributors of hemp-derived beverages
• retailers (grocery, convenience, specialty beverage outlets)
• hemp cultivators and cannabinoid extractors
• federal government (excise tax revenue)

Named in the bill

Tax and Trade Bureau (TTB), FDA / Secretary of Health and Human Services, Secretary of Agriculture, Secretary of Treasury, National Highway Traffic Safety Administration, National Institutes of Health, National Institute of Standards and Technology, Cannabis sativa L., Controlled Substances Act, Federal Alcohol Administration Act, Federal Food, Drug, and Cosmetic Act, Agricultural Marketing Act of 1946 — and 1 more

Where it stands

4 cosponsors: 3 Democrats, 1 Republicans.

• Aug 10, 2026 — Introduced · Congress.gov: “Introduced in House”
• Aug 10, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.